(Q72747532)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6207949%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

title

Antipyrine metabolism in patients with disseminated testicular cancer and the influence of cytostatic treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6207949%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference

1 reference

29 August 2023

1 reference

29 August 2023

3

D. T. Sleijfer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6207949

29 August 2023

author name string

M. W. Teunissen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6207949

29 August 2023

P. H. Willemse

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6207949

29 August 2023

W. J. Sluiter

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6207949

29 August 2023

D. D. Breimer

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6207949

29 August 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6207949

29 August 2023

publication date

1 January 1984

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6207949%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

28 October 2019

http://link.springer.com/content/pdf/10.1007/BF00269025.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF00269025/fulltext.html

29 August 2023

1 reference

http://link.springer.com/content/pdf/10.1007/BF00269025

29 August 2023

1 reference

Cancer Chemotherapy and Pharmacology

29 August 2023

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6207949%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6207949%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6207949%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

page(s)

181-185

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6207949%20AND%20SRC:MED&resulttype=core&format=json

Differential effects of enzyme induction on antipyrine metabolite formation

28 October 2019

cites work

1 reference

12 December 2020

The antipyrine test in clinical pharmacology: Conceptions and misconceptions

1 reference

12 December 2020

Drug metabolism and androgen control therapy in prostatic cancer

1 reference

12 December 2020

Assessment of Methods to Identify Sources of Interindividual Pharmacokinetic Variations

1 reference

12 December 2020

3-Hydroxymethyl antipyrine excretion in urine after an oral dose of antipyrine. A reconsideration of previously published data and synthesis of a pure reference substance

1 reference

12 December 2020

Interindividual variations in drug disposition. Clinical implications and methods of investigation

1 reference

12 December 2020

Antipyrine clearance and metabolite formation in patients with alcoholic cirrhosis

1 reference

12 December 2020

A non-invasive method for the study of hepatic drug metabolism in rodents: antineoplastic drug effects on antipyrine metabolism in mice

1 reference

12 December 2020

A statistical review of malignant testicular tumours based on the experience of the Ontario Cancer Foundation Clinics, 1938-1961

1 reference

12 December 2020

Clinical pharmacokinetics of commonly used anticancer drugs.

1 reference

12 December 2020

Alterations in thyroid hormone metabolism during chemotherapy in patients with testicular carcinoma

1 reference

12 December 2020

Microsomal enzymes in patients with acute leukemia as determined by plasma half-life of antipyrine

1 reference

12 December 2020

Microsomal enzymes in patients with gastric carcinoma as determined by plasma half-life of antipyrine.

1 reference

12 December 2020

Individual Differences in the Disposition of Drugs Metabolised in the Body

1 reference

12 December 2020

Differential induction of antipyrine metabolism by rifampicin.

1 reference

12 December 2020

Assay of Antipyrine and Its Primary Metabolites in Plasma, Saliva and Urine by High-Performance Liquid Chromatography and Some Preliminary Results in Man

1 reference

12 December 2020

Studies on the Different Metabolic Pathways of Antipyrine in Rats: Influence of Phenobarbital and 3-Methylcholanthrene Treatment

1 reference

12 December 2020

Influence of 9-hydroxyellipticine and 3-methylcholanthrene treatment on antipyrine metabolite formation in rats in vivo

1 reference

12 December 2020

Cis-Diamminedichloroplatinum, Vinblastine, and Bleomycin Combination Chemotherapy in Disseminated Testicular Cancer

1 reference

12 December 2020

Decrease in the substrate interaction with cytochrome P-450 in drug hydroxylation by liver microsomes from rats bearing Walker 256 carcinosarcoma

1 reference

12 December 2020

Comparative pharmacokinetics of vindesine, vincristine and vinblastine in patients with cancer

1 reference

12 December 2020

Antipyrine clearance per unit volume liver: an assessment of hepatic function in chronic liver disease

1 reference

12 December 2020

The effect of antineoplastic drugs on the pharmacokinetics of antipyrine in the rat.

1 reference

12 December 2020

Bleomycin pharmacokinetics in man. I. Intravenous administration

1 reference

12 December 2020

Automated high-performance liquid chromatographic determination of antipyrine and its main metabolites in plasma, saliva and urine, including 4,4'-dihydroxyantipyrine

1 reference

12 December 2020

The effect of anti-cancer drugs on the plasma disposition of antipyrine and the biliary excretion of phenolphthalein in the rat

1 reference

12 December 2020

Metabolic disposition of antipyrine in patients with lung cancer

1 reference

12 December 2020

Bleomycin inhibits hepatic mixed function oxidation

1 reference

12 December 2020

Antipyrine metabolism and bronchogenic carcinoma

1 reference

12 December 2020

Studies of the different metabolic pathways of antipyrine in man. Oral versus i.v. administration and the influence of urinary collection time

1 reference

12 December 2020

Variation of microsomal mixed function oxidase(s) and human lung cancer

1 reference

12 December 2020

Combination chemotherapy with cis-diammine-dichloro-platinum, vinblastine, and bleomycin in advanced testicular non-seminoma

1 reference

12 December 2020

The pattern of gamma-glutamyl transpeptidase, alkaline phosphatase, serum glutamyl oxalate transaminase and serum glutamyl pyruvate transaminase in patients with disseminated non-seminomatous testicular tumors

1 reference

12 December 2020

Genetic and environmental factors affecting drug disposition in man

1 reference

12 December 2020

Inhibition of Drug Oxidation and Stimulation of NADPH Oxidase in vitro by Doxorubicin and Triferric-Doxorubicin

1 reference

12 December 2020

Impairment of drug metabolism in patients with liver cancer

1 reference

12 December 2020

Research Communications in Chemical Pathology and Pharmacology

23

34

278

MR Montgomery

1981

1 reference

Influence of rifampicin treatment on antipyrine clearance and metabolite formation in patients with tuberculosis

29 August 2023

31

1 reference

29 August 2023

Identifiers

DOI

10.1007/BF00269025

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6207949%20AND%20SRC:MED&resulttype=core&format=json

28 October 2019

1 reference